Please login to the form below
symptoms
This page shows the latest symptoms news and features for those working in and with pharma, biotech and healthcare.
Tox trouble stalls Sosei/Allergan Alzheimer’s drug
HTL0018318 acts as a selective M1 agonist that could provide another way of treating the symptoms of dementia by improving cholinergic neurotransmission, acting via a different mechanism to already-approved anticholinesterase ... for neurobehavioural
Latest news
-
London cancer hub launched by Cancer Research UK
I was very lucky – I’d had no symptoms, but I was having regular blood tests because of medication I was on for another condition and it was one of those
-
Rival Opdivo rejected, Novartis combo gets NICE green light in adjuvant melanoma
disease which can cause severe and debilitating symptoms.
-
New data keeps AbbVie’s star pipeline therapies on track
New data keeps AbbVie’ s star pipeline therapies on track. Data showed 56% of patients on risankizumab were symptom free after a year’s treatment. ... The analysis showed that 56% of patients on risankizumab were symptom-free after a year’s
-
Shire’s bleeding disorder drug approved in Europe
Patients with VWD usually are deficient in this protein, and affected individuals have symptoms including nosebleeds, bleeding from the gums and easy bruising.
-
FDA rejects GSK’s Nucala for COPD
of symptoms – in COPD patients with elevated eosinophil level.
More from news
Approximately 2 fully matching, plus 1,038 partially matching documents found.
Latest Intelligence
-
Cancer in The Information Age: are we illuminated or inundated?
But to do this, communication is crucial. A shining example is MoovCare, a web-based application through which patients report their own symptoms of lung cancer to enable earlier detection of
-
The Big Book of Dashboards
Working out the average symptoms for all patients might provide a picture for those governing the healthcare provider, but the overall average is of no use to the provider trying to
-
The challenges of making genomics a reality for patients
The symptom most commonly associated with the condition is progressive lung damage, but cystic fibrosis affects a multitude of organs in the body meaning half of patients don’t make it
-
A new era of smart pharma
It must be used alongside diligent medical care so that patients with paranoid symptoms feel reassured rather than have their condition reinforced.
-
Health on instalment
Gene therapies target the underlying disease itself, not symptoms, and often fix the problem permanently.
More from intelligence
Approximately 0 fully matching, plus 70 partially matching documents found.
Latest appointments
-
Srdjan Stankovic joins Acadia Pharmaceuticals
Acadia is at the forefront in developing groundbreaking medicines to treat debilitating symptoms associated with these diseases.
-
Bayer's Kirstyn Nicholas joins Spirit Healthcare
Nicholas has previously specialised in the provision of medical devices designed to help manage screening, symptoms and treatment.
-
Ex-Bayer R&D chief joins Gemmus Pharma board
San Francisco-based Gemmus was founded in 2007 and is developing a drug that decreases the severity of flu symptoms by modulating the release of pro-inflammatory cytokines.
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Medopad: the up and coming unicorn transforming remote patient monitoring
An organisation can choose from more than 100 data-capture modules, including 6-minute walking tests, questionnaires, medicine and symptom trackers, and AI video capture. ... These patients have historically been underserved by healthcare services, which
-
Irritable Bowel Syndrome (IBS) Patient Insights
underestimate the severity of IBS symptoms . understate global effect on quality of life . ... You may have long periods of time (sometimes years) without experiencing any symptoms.".
-
Alzheimer's and Brain Awareness Month
Its symptoms include memory loss and difficulty with thinking, problem solving and language2, 3. ... Amongst these are cholinesterase inhibitors, which increase acetylcholine levels that help ease and stabilize the symptoms of AD.
-
The power of the patient
the symptoms.
-
Raising Awareness: It’s World COPD Day today!
The smaller airways also become scarred and narrowed. These changes cause the symptoms of breathlessness, cough and phlegm that are associated with COPD. ... If the patient’ s symptoms are not completely controlled with bronchodilators alone, ICS may
More from PMHub
Approximately 0 fully matching, plus 86 partially matching documents found.
Featured jobs
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
-
Senior Training Manager - Surrey
-
Competitive Salary &Bonus
- Senior Strategist/ Planner, Healthcare Marketing, London
-
Excellent package
-
Healthcare PR Senior Account Manager
-
Salary TBC
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
Senior Medical Writer
-
Salary is DOE
-
Sudler London - Account Director
-
Competitive
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Senior Medical Writer, Principal Medical Writer, Scientific Dire...
-
£40000 - £75000 Bonus Benefits
-
Associate Scientific Director
-
Salary TBC
- Integrated Brand/ Digital Senior Account Director, London
-
Excellent package
- Sudler London - Senior Medical Writer
-
Competitive
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Systematic Review Lead- London
-
Negotiable
-
Account Manager
-
Negotiable
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
Subscribe to our email news alerts
- More tell, less sell: HCP-centric comms
- Anna Korving to step down as Chair of Communiqué Awards judging panel
- Double win for Pegasus at the Communique awards 2018
- CRUK forges £30m ‘post-Brexit’ R&D alliance
- Nurturing the growth mindset: The need for ongoing professional development in strategic medical communications
- Innovate UK supports AI drug discovery project worth £1m
PMHub
Synergy Vision
Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...
Latest intelligence
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
- What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
- GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....
Quick links
Infographics
